Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

May 19, 2020

Witt v. Novartis Pharmaceuticals Corporation

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 29, 2021

    Novartis Cancer Drug Suits Too Few To Centralize, JPML Told

    Novartis Pharmaceuticals Inc. told the Judicial Panel on Multidistrict Litigation on Thursday that suits alleging its blood cancer drug Tasigna causes cardiovascular disease should not be consolidated, since the company believes it is unlikely that significantly more suits will be filed in federal court.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login